Drugs / Zmax
last change Dec 2006 re-read 3 minutes ago

Zmax

Developed for
otitis media
Investigated by
Pfizer

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00360100 Aug → Dec 2006 otitis media Pfizer Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Zmax ClinicalTrials.gov intervention name — accepted as the source's own label NCT00360100 ↗
Route Oral “single oral 60 Mg/Kg dose of Zmax” NCT00360100 ↗